Disparities in engagement in care and viral suppression among persons with HIV

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 1, 2013, Pages 112-119

  Muthulingam, Dharushana ^a   Chin, Jennie ^b   Hsu, Ling ^b   Scheer, Susan ^b   Schwarcz, Sandra ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

disparities; engagement in care; HIV care; HIV surveillance; persons with HIV; viral suppression

Indexed keywords

ADOLESCENT; ADULT; AFRICAN AMERICAN; AGE; ARTICLE; ASIAN; DISEASE SURVEILLANCE; EUROPEAN AMERICAN; FEMALE; GENDER; HEALTH CARE DISPARITY; HEALTH INSURANCE; HETEROSEXUAL MALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMELESSNESS; HOUSING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MALE HOMOSEXUAL; MEDICAL EXAMINATION; OUTCOME ASSESSMENT; PATIENT CARE; PREDICTION; PRIORITY JOURNAL; RACE; RESIDENTIAL AREA; SOCIAL STATUS; TREATMENT FAILURE; UNITED STATES;

ADOLESCENT; ADULT; AGE FACTORS; CD4 LYMPHOCYTE COUNT; DELIVERY OF HEALTH CARE; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INSURANCE COVERAGE; INSURANCE, HEALTH; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; RNA, VIRAL; SAN FRANCISCO; SOCIOECONOMIC FACTORS; VIRAL LOAD; YOUNG ADULT;

EID: 84876287472     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e3182894555     Document Type: Article

References (90)

1. Mocroft A, Vella S, Benfield T, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet. 1998;352:1725-1730.
2. Department of Health and Human Services Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-infected adults and adolescents. Available at: http://aidsin-fo.nih.ogv/contentfiles/lvguidelines/AdultandAdolescentGL.pdf. Accessed April 4, 2012.
3. Palella FJ, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338: 853-860.
4. Vittinghoff E, Scheer S, O'Malley P, et al. Combination antiretroviral therapy and recent declines in AIDS incidence and mortality. J Infect Dis. 1999;179:717-720.
5. The Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet. 2008; 372:293-299.
6. García F, De Lazzari E, Plana M, et al. Long-term CD4+ T-cell response to highly active antiretroviral therapy according to baseline CD4+ T-cell count. J Acquir Immune Defic Syndr. 2004;36:702-713.
7. Wood E, Kerr T, Marshall BDL, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.
8. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921-929.
9. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301:2380-2382.
10. Montaner JSG, Hogg R, Wood E, et al. The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet. 2006;368:531-536.
11. White House Office of National AIDS Policy. National HIV/AIDS Strategy for the United States (July 2010). Available at: http://www.whitehouse. gov/sites/default/files/uploads/NHAS.pdf. Accessed March 29, 2012.
12. Gardner EM, McLees MP, Steiner JF, et al. The spectrum of engagement in HIV care and its relevance to test-and-treat strategies for prevention of HIV infection. Clin Infect Dis. 2011;52:793-800.
13. Cohen SM, Van Handel MM, Branson BM, et al. Vital Signs: HIV Prevention Through Care and Treatment-United States. MMWR Morb Mortal Wkly Rep. 2011;60:1618-1622.
14. Laffoon B, Johnson AS, Cohen S, et al. National black HIV/AIDS awareness disparities in diagnoses of HIV infection between blacks/African Americans and other racial/eEthnic populations-37 States, 2005-2008. MMWR Morb Mortal Wkly Rep. 2011;60:1999-2002.
15. Centers for Disease Control and Prevention. HIV Surveillance Report, 2008. Available at: http://www.cdc.gov/topics/surveillance/resources/reports/. Accessed March 29, 2012.
16. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2006. Atlanta, Georgia: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2008: 1-11.
17. Prejean J, Song R, Hernandez A, et al. Estimated HIV Incidence in the United States, 2006-2009. PLoS ONE. 2011;6:e17502.
18. Harawa NT, Greenland S, Bingham TA, et al. Associations of race/ethnicity with HIV prevalence and HIV-related behaviors among young men who have sex with men in 7 urban centers in the United States. JAcquir Immune Defic Syndr. 2004;35:526-536.
19. Christopoulos KA, Das M, Colfax GN. Linkage and retention in HIV care among men who have sex with men in the United States. Clin Infect Dis. 2011;52(suppl 2):S214-S222.
20. Millett GA, Flores SA, Peterson JL, et al. Explaining disparities in HIV infection among black and white men who have sex with men: a metaanalysis of HIV risk behaviors. AIDS. 2007;21:2083-2091.
21. Nakashima A, Campsmith M, Wolfe M, et al. Late versus early testing of HIV-16 Sites, United States, 2000-2003. MMWR Morb Mortal Wkly Rep. 2003;52:581-586.
22. Chen NE, Gallant JE, Page KR. A systematic review of HIV/AIDS survival and delayed diagnosis among Hispanics in the United States. JImmigr Minor Health. 2012;14:65-81.
23. Dennis AM, Napravnik S, Seña AC, et al. Late entry to HIV care among Latinos compared with non-Latinos in a southeastern US cohort. Clin Infect Dis. 2011;53:480-487.
24. Saganic L, Carr J, Solorio R, et al. Comparing measures of late HIV diagnosis in Washington State. AIDS Res Treat. 2012;2012:182672.
25. Schwarcz S, Hsu L, Dilley JW, et al. Late diagnosis of HIV infection: trends, prevalence, and characteristics of persons whose HIV diagnosis occurred within 12 months of developing AIDS. JAcquir Immune Defic Syndr. 2006;43:491-494.
26. Schwarcz SK, Hsu L, Chin C-SJ, et al. Do people who develop AIDS within 12 months of HIV diagnosis delay HIV testing? Public Health Rep. 2011;126:552-559.
27. Tang JJ, Levy V, Hernandez MT. Who are California's late HIV testers? An analysis of state AIDS surveillance data, 2000-2006. Public Health Rep. 2011;126:338-343.
28. Milberg J, Sharma R, Scott F, et al. Factors associated with delays in accessing HIV primary care in rural Arkansas. AIDS Patient Care STDS. 2001;15:527-532.
29. Hsu LC, Chen M, Kali J, et al. Assessing receipt of medical care and disparity among persons with HIV/AIDS in San Francisco, 2006-2007. AIDS Care. 2011;23:383-392.
30. Tripathi A, Gardner LI, Ogbuanu I, et al. Predictors of time to enter medical care after a new HIV diagnosis: a statewide population-based study. AIDS Care. 2011;23:1366-1373.
31. Gebo KA, Fleishman JA, Conviser R, et al. Racial and gender disparities in receipt of highly active antiretroviral therapy persist in a multistate sample of HIV patients in 2001. J Acquir Immune Defic Syndr. 2005;38: 96-103.
32. Wood E, Montaner JSG, Bangsberg DR, et al. Expanding access to HIV antiretroviral therapy among marginalized populations in the developed world. AIDS. 2003;17:2419-2427.
33. Hall HI, Gray KM, Tang T, et al. Retention in care of adults and adolescents living with HIV in 13 U.S. areas. J Acquir Immune Defic Syndr. 2012;60:77-82.
34. Tobias CR, Cunningham W, Cabral HD, et al. Living with HIV but without medical care: barriers to engagement. AIDS Patient Care STDS. 2007;21:426-434.
35. Wolitski RJ, Kidder DP, Pals SL, et al. Randomized trial of the effects of housing assistance on the health and risk behaviors of homeless and unstably housed people living with HIV. AIDS Behav. 2010;14: 493-503.
36. Ryscavage P, Anderson E, Sutton S. Clinical outcomes of adolescents and young adults in adult HIV care. J Acquir Immune Defic Syndr. 2011; 58:193-197.
37. Sohler NL, Li X, Cunningham CO. Gender disparities in HIV health care utilization among the severely disadvantaged: can we determine the reasons? AIDS Patient Care STDS. 2009;23:775-783.
38. Oh DL, Sarafian F, Silvestre A, et al. Evaluation of adherence and factors affecting adherence to combination antiretroviral therapy among White, Hispanic, and Black men in the MACS Cohort. J Acquir Immune Defic Syndr. 2009;52:290-293.
39. Sullivan PS, Campsmith ML, Nakamura G V, et al. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy. PLoS ONE. 2007;2:e552.
40. Schackman BR, Ribaudo HJ, Krambrink A, et al. Racial differences in virologic failure associated with adherence and quality of life on efavir-enz-containing regimens for initial HIV therapy: results of ACTG A5095. J Acquir Immune Defic Syndr. 2007;46:547-554.
41. Zetola NM, Bernstein K, Ahrens K, et al. Using surveillance data to monitor entry into care of newly diagnosed HIV-infected persons: San Francisco, 2006-2007. BMC Public Health. 2009;9:17.
42. State of California, Department of Public Health. Requirements for HIV case and CD4 test result reporting. California Health and Safety Code, Sections 121022-121023. Available from: http://www.leginfo.ca.gov/c-gi-bin/displaycode? section=hsc&group=120001-121000&file=120975-121023. Accessed April 3, 2012.
43. Schwarcz SK, Hsu LC, Vittinghoff E, et al. Impact of housing on the survival of persons with AIDS. BMC Public Health. 2009;9:1-18.
44. U.S. Census Bureau. 2006-2010 American Community Survey. 2010.
45. Schneider E, Whitmore S, Glynn MK, et al. Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged < 18 months and for HIV infection and AIDS among children aged 18 months to < 13 Years-United States, 2008. MMWR Recomm Rep. 2008;57:1-12.
46. Chu PL, Hsu LC, Schwarcz SK. Comparison of methods to measure the completeness of HIV/AIDS reporting in San Francisco. Presented at: Oral Abstract Session: AIDS 2008-XVII International AIDS Conference; Mexico City, Mexico: August 3-8, 2008.
47. Schwarcz SK, Hsu LC, Parisi MK, et al. The impact of the 1993 AIDS case definition on the completeness and timeliness of AIDS surveillance. AIDS. 1999;13:1109-1114.
48. San Francisco Department of Public Health. HIV/AIDS Epidemiology Annual Report. San Francisco, CA:San Francisco Department of Public Health; 2008.
49. Centers for Disease Control and Prevention. CDC HIV Prevention Strategic Plan: Extended through 2010. Available at: http://www.cdc.gov/-hiv/resources/ reports/psp/pdf/psp.pdf Accessed April 3, 2012.
50. Mugavero MJ, Lin H-Y, Willig JH, et al. Missed visits and mortality among patients establishing initial outpatient HIV treatment. Clinical Infectious Diseases. 2009;48(2):248-56.
51. Centers for Disease Control and Prevention. Using viral load data to monitor HIV burden and treatment outcomes in the United States CDC activities to address challenges in calculating viral load measures. 2012. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/fact-sheets/viral-load.htm. Accessed February 15, 2012.
52. Leaver CA, Bargh G, Dunn JR, et al. The effects of housing status on health-related outcomes in people living with HIV: a systematic review of the literature. AIDS Behav. 2007;11:85-100.
53. Aidala AA, Sumartojo E. Why Housing? AIDS Behav. 2007;11:1-6.
54. Furlotte C, Schwartz K, Koornstra JJ, et al. "Got a room for me?" Housing experiences of older adults living with HIV/AIDS in Ottawa. Can J Aging. 2012;31:37-48.
55. Henry R, Richardson JL, Stoyanoff S, et al. HIV/AIDS health service utilization by people who have been homeless. AIDS Behav. 2008;12: 815-821.
56. Cunningham CO, Sohler NL, Wong MD, et al. Utilization of health care services in hard-to-reach marginalized HIV-infected individuals. AIDS Patient Care STDS. 2007;21:177-186.
57. Chen NE, Meyer JP, Avery AK, et al. Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav. 2011.
58. Smith MY, Rapkin BD, Winkel G, et al. Housing status and health care service utilization among low-income persons with HIV/AIDS. J Gen Intern Med. 2000;15:731-738.
59. Gelberg L, Gallagher TC, Andersen RM, et al. Competing priorities as a barrier to medical care among homeless adults in Los Angeles. Am J Public Health. 1997;87:217-220.
60. Breakey WR, Fischer PJ, Kramer M, et al. Health and mental health problems of homeless men and women in Baltimore. JAMA. 1989;262: 1352-1357.
61. Kidder DP, Wolitski RJ, Campsmith ML, et al. Health status, health care use, medication use, and medication adherence among homeless and housed people living with HIV/AIDS. Am J Public Health. 2007;97: 2238-2245.
62. Buchanan D, Kee R, Sadowski LS, et al. The health impact of supportive housing for HIV-positive homeless patients: a randomized controlled trial. Am J Public Health. 2009;99:S675-S680.
63. Bindman AB, Grumbach K, King TE. Health care disparities: An overview. In: King TE, Wheeler MB, eds. Medical Management of Vulner-able and Underserved Patients: Principles, Practice, and Populations. New York, NY: McGraw-Hill; 2007:13-25.
64. Fiscella K, Williams DR. Health disparities based on socioeconomic inequities: implications for urban health care. Acad Med. 2004;79: 1139-1147.
65. Isaacs SL, Schroeder SA. Class-the ignored determinant of the Nation's health. N Engl J Med. 2004;351:1137-1142.
66. Marmot MG, Rose G, Shipley M, et al. Employment grade and coronary heart disease in British civil servants. J Epidemiol Community Health. 1978;32:244-249.
67. Shapiro M, Morton S. Variations in the care of HIV-infected adults in the United States. J Am Med Assoc. 1999;281:2305-2315.
68. McMahon J, Wanke C, Terrin N, et al. Poverty, hunger, education, and residential status impact survival in HIV. AIDSBehav. 2011;15:1503-1511.
69. McFarland W, Chen S, Hsu L, et al. Low socioeconomic status is associated with a higher rate of death in the era of highly active antiretroviral therapy, San Francisco. JAcquir Immune Defic Syndr. 2003;33:96-103.
70. Uphold CR, Mkanta WN. Use of health care services among persons living with HIV infection: State of the science and future directions. AIDS Patient Care STDS. 2005;19:473-485.
71. Kerr JC, Stephens TG, Gibson JJ, et al. Risk factors associated with inpatient hospital utilization in HIV-positive individuals and relationship to HIV care engagement. J Acquir Immune Defic Syndr. 2012;60:173-182.
72. Palacio H, Shiboski C, Yelin E, et al. Access to and utilization of primary care services among HIV-infected women. J Acquir Immune Defic Syndr. 1999;21:293-300.
73. Bhattacharya J, Goldman D, Sood N. The link between public and private insurance and HIV-related mortality. J Health Econ. 2003;22:1105-1122.
74. Riley ED, Gandhi M, Hare C, et al. Poverty, unstable housing, and HIV infection among women living in the United States. Curr HIV/AIDS Rep. 2007;4:181-186.
75. Torian L V, Wiewel EW. Continuity of HIV-related medical care, New York City, 2005-2009: do patients who initiate care stay in care? AIDS Patient Care STDS. 2011;25:79-88.
76. Stone VE. HIV/AIDS in women and racial/ethnic minorities in the U.S. Curr Infect Dis Rep. 2012;14:53-60.
77. San Francisco Department of Public Health. HIV/AIDS Epidemiology Annual Report. San Francisco, CA: San Francisco Department of Public Health; 2010.
78. Benbow N, Scheer S, Wohl A, et al. Linkage, retention, ART use and viral suppression in four large cities in the United States. Presented at: 19th International AIDS Conference; Washington, DC: July 22-27, 2012. Abstract MOPDC0303.
79. Havlir D V, Bassett R, Levitan D, et al. Prevalence and predictive value of intermittent viremia with combination HIV therapy. JAMA. 2001;286: 171-179.
80. Martinez V, Marcelin A-G, Morini JP, et al. HIV-1 intermittent viraemia in patients treated by non-nucleoside reverse transcriptase inhibitor-based regimen. AIDS. 2005;19:1065-1069.
81. Sungkanuparph S, Overton ET, Seyfried W, et al. Intermittent episodes of detectable HIV viremia in patients receiving nonnucleoside reverse-transcriptase inhibitor-based or protease inhibitor-based highly active antiretroviral therapy regimens are equivalent in incidence and prognosis. Clin Infect Dis. 2005;41:1326-1332.
82. Charpentier C, Landman R, Laouénan C, et al. Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome. J Antimicrob Chemother. 2012;67:2231-2235.
83. Winkleby MA, Jatulis DE, Frank E, et al. Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease. Am J Public Health. 1992;82:816-820.
84. Shacham E, Nurutdinova D, Onen N, et al. The interplay of sociodemo-graphic factors on virologic suppression among a U.S. outpatient HIV clinic population. AIDS Patient Care STDS. 2010;24:229-235.
85. Zaller ND, Fu JJ, Nunn A, et al. Linkage to care for HIV-infected heterosexual men in the United States. Clin Infect Dis. 2011;52(suppl 2): S223-S230.
86. Meyer JP, Chen NE, Springer SA. HIV treatment in the criminal justice system: critical knowledge and intervention gaps. AIDS Res Treat. 2011; 2011:680617.
87. Gonzalez JS, Hendriksen ES, Collins EM, et al. Latinos and HIV/AIDS: examining factors related to disparity and identifying opportunities for psychosocial intervention research. AIDS Behav. 2009;13:582-602.
88. Wolfson MC, Kaplan G, Lynch J, et al. Relation between income inequality and mortality: empirical demonstration. West J Med. 1999; 172:22-24.
89. Centers for Disease Control and Prevention. Cases of HIV infection and AIDS in the United States and dependent areas, by race/ethnicity, 2003-2007. HIV/AIDS Surveillance Suppl Rep. 2009;14:2007-2008.
90. IOM (Institute of Medicine). Monitoring HIV Care in the United States: Indicators and Data Systems Committee to Review Data Systems for Monitoring HIV Care Board on Population Health and Public Health Practice. Washington, DC: National Academies Press. 2012.